RLMD
Relmada Therapeutics Inc

1,871
Mkt Cap
$69.7M
Volume
323,234.00
52W High
$3.98
52W Low
$0.2404
PE Ratio
-0.95
RLMD Fundamentals
Price
$2.33
Prev Close
$2.10
Open
$2.26
50D MA
$1.61
Beta
0.49
Avg. Volume
892,899.86
EPS (Annual)
-$2.65
P/B
4.37
Rev/Employee
$0.00
Loading...
Loading...
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
17

Frequently Asked Questions

What is Market Cap of Relmada Therapeutics Inc?
What is the 52-week high for Relmada Therapeutics Inc?
What is the 52-week low for Relmada Therapeutics Inc?
What is Relmada Therapeutics Inc stock price today?
What was Relmada Therapeutics Inc stock price yesterday?
What is the PE ratio of Relmada Therapeutics Inc?
What is the Price-to-Book ratio of Relmada Therapeutics Inc?
What is the 50-day moving average of Relmada Therapeutics Inc?
How many employess does Relmada Therapeutics Inc has?

Latest RLMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.